Abstract B063: Exploring combination therapies to overcome RAS inhibitor resistance in pancreatic cancer
RASi-resistant in vitro and in vivo models of murine and human PDAC are generated to inform the development of more effective combination strategies for PDAC by defining resistance mechanisms and revealing therapeutic vulnerabilities, with potential implications for translational efforts in a disease with significant u...